Brian Slater and Greg Sephton Join Sterlington to bolster IP and Life Sciences practice areas

News

Sterlington is proud to announce the strategic addition of two senior partners to its team as Co-Heads of Sterlington’s Intellectual Property (IP) practice.

New York, September 29, 2023 – Sterlington is proud to announce the strategic addition of two senior partners to its team as Co-Heads of Sterlington’s Intellectual Property (IP) practice. With their extensive experience in IP and life sciences, the appointments of Brian Slater and Greg Sephton mark another significant step in the firm’s commitment to providing top-tier legal counsel to clients.

Brian Slater is a lead trial lawyer who has represented industry giants including Gilead, Merck, Novartis, Regeneron, and Sanofi, in high-stakes intellectual property disputes. Greg Sephton has also represented pharmaceutical and biotechnology innovators, including AstraZeneca, Novartis, Merck, and Regeneron, in high-stakes patent litigation. They both have extensive experience in high value Hatch-Waxman patent litigations representing branded pharmaceutical companies against generic drug challengers, as well as bet-the-company patent cases involving biologics and lipid nanoparticle technology. They also counsel emerging and established life sciences companies on protecting, licensing, and monetizing their IP assets.

Among his prior firms, Brian was a partner at Kramer Levin Naftalis & Frankel LLP, where he was Chair of Life Sciences. Before that, he spent over 20 years at the IP boutique, Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he served on the management committee. Brian has been recognized by Intellectual Asset Management Patent 1000: The World’s Leading Patent Professionals, and as a Life Sciences Lawyer by LMG Life Sciences. He obtained his LL.M. from the University of Pennsylvania, where he was a Thouron Scholar.

Among his prior firms, Greg was a partner at Kramer Levin Naftalis & Frankel LLP and before that, was a partner at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP), where he practiced for more than 20 years. He obtained his J.D. from Suffolk University, his Ph.D. in biochemistry from Brandeis University and his B.Sc. (Hons) in chemistry and biochemistry from the University of Toronto.

Commenting on the appointments, Chris Harrison, founding partner of Sterlington said “We are delighted to welcome Brian and Greg to our team here at Sterlington. Their significant expertise in IP litigation and strong relationships within the life sciences industry will enhance our capabilities and our position as a trusted legal partner in this area.”

Read full bios:

About Sterlington PLLC

Sterlington PLLC is an international virtual law firm with leading capabilities in sophisticated litigation and transactional work, and legal operations outsourcing. With deep experience and specialized skills across multiple practices and industries, our team helps clients around the world achieve their business goals.

Recent News
& Insights

All News & Insights
All News & Insights
Blog

BVI Sets Precedent: Landmark Ruling on Foreign Judgment Enforcement at Common Law

The BVI Commercial Court has issued a landmark decision clarifying the common-law principles surrounding the enforcement of foreign judgments. In Cashman Equipment Corp v EMCS Caribbean Ltd, the court upheld a U.S. judgment against a BVI company, providing a detailed analysis of jurisdictional requirements and defenses for practitioners. For detailed insights, read below.

Blog

Contract Lifecycle Management Best Practices You Should Be Following in 2024

Outsourcing contract management empowers in-house teams and executives to focus on strategic tasks by leveraging expertise, cost-effectiveness, and streamlined processes. With organizations managing thousands of contracts, effective lifecycle management is critical. Challenges like stakeholder alignment and resource drain necessitate robust practices such as centralized repositories and automation.

Blog

Adding Insult to Injury – Termination and Bonus Season

The timing of terminations just before bonus payouts often sparks concerns about fairness, particularly in finance, where bonuses form a significant part of yearly income. Whether contractual or discretionary - or anything in between - the type of bonus defines entitlements. Severance packages typically overlook bonuses, causing financial strain for terminated employees banking on them. Understanding bonus types and contract clauses becomes crucial in navigating post-termination entitlements, underscoring the importance of seeking legal counsel to protect one's rights.